ゴーシェ病治療薬の日本市場:市場インサイト、疫学分析、市場予測

◆英語タイトル:Gaucher’s disease - Market Insights, Epidemiology and Market Forecast – 2023 - Japan
◆商品コード:DLVE704006
◆発行会社(リサーチ会社):DelveInsight
◆発行日:2017年1月
◆ページ数:88
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2営業日以内)
◆調査対象地域:日本
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,750 ⇒換算¥192,500見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD5,250 ⇒換算¥577,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はDelveInsight社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

DelveInsight’s “Gaucher’s disease – Market Insights, Epidemiology and Market Forecast – 2023 – Japan” Reports provides an overview of the disease and global market size of the Gaucher disease for the Japan. It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Gaucher disease from 2010-2023. According to Publisher, the forecasted patient population of Gaucher disease will increase at a CAGR of XX% from 2010 to 2023 and the worldwide Gaucher disease market is estimated to be USD XX Million by 2023.Gaucher disease is an inherited genetic disease that causes fatty lipid deposits to build up in certain organs and bones. It is an autosomal recessive disorder. Gaucher Disease is the second most common lysosomal storage disorder. These fatty deposits are of an enzyme glucocerebrosidase in the lymphocyte which leads to bloating of cells.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Scope
- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
- Marketed information including available prescription drugs, its patent and exclusivity details.
- The Report also covers the detailed global historical and forecasted epidemiological data covering Japan from 2010-2023.
- It also provides Market size of Gaucher’s disease for Japan from 2010 and forecasted Market size to 2023.

【レポートの目次】

Report Introduction
Gaucher’s Disease Market Overview at a Glance
Total Market Size of Gaucher’s Disease in 2015
Total Market Size of Gaucher’s Disease in 2023
Gaucher Disease
Overview
Symptoms
Types of Gaucher Disease
Pathophysiology
Inheritance and Genetics related to Gaucher’s Disease
Mutations
Diagnosis
Treatment
Epidemiology and Patient Population
Japan
Diagnosed Cases of Gaucher Disease in Japan
Marketed Drugs
Cerdelga
Drug Description
Mechanism of Action
Regulatory Milestones
Advantages & Disadvantages
Safety and Efficacy of Cerdelga
Product Profile
Zavesca
Drug Description
Mechanism of Action
Regulatory Milestones
Advantages & Disadvantages
Safety and Efficacy of Zavesca
Product Profile
Cerezyme
Drug Description
Mechanism of Action
Regulatory Milestones
Advantages & Disadvantages
Safety and Efficacy of Cerezyme
Product Profile
Vpriv
Drug Description
Mechanism of Action
Regulatory Milestones
Advantages & Disadvantages
Safety and Efficacy of Vpriv
Product Profile
Elelyso
Drug Description
Mechanism of Action
Regulatory Milestones
Advantages & Disadvantages
Safety and Efficacy of Elelyso
Product Profile
Emerging Therapies
Abcertin
Advantages & Disadvantages
Clinical Development
Product Profile
Ongoing Trials Information
Clinical Trial by Phase
Global Gaucher Disease: Country-Wise Market Analysis
Overview on Total Gaucher Disease Market (2015)
Overview on distribution of Total Gaucher Disease Market based on Type of Administration/Therapy (2015)
Japan
Market Drivers
Market Restraints
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

Table 1: Diagnosed Cases Gaucher Disease in Japan (2010-2023)
Table 2: Clinical Trials by Trial status, 2016
Table 3: Japan Market Size of Gaucher Disease in USD, Million (2010-2023)


Figure 1: Pathophysiology of Gaucher Disease
Figure 2: Inheritance of Gaucher Disease
Figure 3: Diagnosed Cases of Gaucher Disease in Japan (2010-2023)
Figure 4: Abcertin, Clinical Trials by Trial status (%), 2016
Figure 5: Total Market Size of Gaucher Disease in USD, Million (2015)
Figure 6: Total Market Size of Gaucher Disease in USD, Million (2015)
Figure 7: Japan Market Size of Gaucher Disease in USD, Million (2010-2023)


【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ゴーシェ病治療薬の日本市場:市場インサイト、疫学分析、市場予測(Gaucher’s disease - Market Insights, Epidemiology and Market Forecast – 2023 - Japan)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆